|
Quotes & Info
|
| NVLT > SEC Filings for NVLT > Form 8-K on 14-Jun-2012 | All Recent SEC Filings |
14-Jun-2012
Regulation FD Disclosure, Financial Statements and Exhibits
A copy of the press release issued by us on June 14, 2012 announcing the closing of the previously disclosed $5.4 million registered public offering of units consisting of our common stock and warrants to purchase our common stock, and the dismissal with prejudice of a pending putative federal securities class action lawsuit against us and Harry S. Palmin, our chief executive officer, is furnished as Exhibit 99.1 and is incorporated by reference.
(d) Exhibits
Number Title
99.1 Press Release dated June 14, 2012 entitled "Novelos
Therapeutics Closes $5.4 Million Public Offering, Announces
Dismissal With Prejudice Of Putative Federal Securities Class
Action Lawsuit"
|
|
|